Your browser doesn't support javascript.
loading
Correction: A novel approach for relapsed/refractory FLT3mut+acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib.
Li, Ke-Xin; Wu, Hui-Yang; Pan, Wan-Ying; Guo, Meng-Qi; Qiu, De-Zhi; He, Yan-Jie; Li, Yu-Hua; Yang, Dong-Hua; Huang, Yu-Xian.
  • Li KX; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Wu HY; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Pan WY; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Guo MQ; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Qiu DZ; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • He YJ; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Li YH; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
  • Yang DH; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. yangd1@stjohns.edu.
  • Huang YX; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. hyx6610@163.com.
Mol Cancer ; 21(1): 134, 2022 Jun 23.
Article en En | MEDLINE | ID: mdl-35739513